NL191332C - Pharmaceutical preparation with the ethyl ester of (all-Z) -5,8,11,14,17-eicosapentaenoic acid. - Google Patents

Pharmaceutical preparation with the ethyl ester of (all-Z) -5,8,11,14,17-eicosapentaenoic acid.

Info

Publication number
NL191332C
NL191332C NL7904144A NL7904144A NL191332C NL 191332 C NL191332 C NL 191332C NL 7904144 A NL7904144 A NL 7904144A NL 7904144 A NL7904144 A NL 7904144A NL 191332 C NL191332 C NL 191332C
Authority
NL
Netherlands
Prior art keywords
ethyl ester
pharmaceutical preparation
eicosapentaenoic acid
eicosapentaenoic
acid
Prior art date
Application number
NL7904144A
Other languages
Dutch (nl)
Other versions
NL191332B (en
NL7904144A (en
Original Assignee
Mochida Pharm Co Ltd
Nippon Suisan Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB2357578A external-priority patent/GB1604554A/en
Application filed by Mochida Pharm Co Ltd, Nippon Suisan Kaisha Ltd filed Critical Mochida Pharm Co Ltd
Publication of NL7904144A publication Critical patent/NL7904144A/en
Publication of NL191332B publication Critical patent/NL191332B/en
Application granted granted Critical
Publication of NL191332C publication Critical patent/NL191332C/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C15/00—Butter; Butter preparations; Making thereof
    • A23C15/12—Butter preparations
    • A23C15/126—Butter containing a minority of vegetable oils; Enrichment of butter with fatty acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
    • A23D9/013—Other fatty acid esters, e.g. phosphatides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NL7904144A 1978-05-26 1979-05-25 Pharmaceutical preparation with the ethyl ester of (all-Z) -5,8,11,14,17-eicosapentaenoic acid. NL191332C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2357478 1978-05-26
GB2357578A GB1604554A (en) 1978-05-26 1978-05-26 Pharmaceutical and food formulations

Publications (3)

Publication Number Publication Date
NL7904144A NL7904144A (en) 1979-11-28
NL191332B NL191332B (en) 1995-01-02
NL191332C true NL191332C (en) 1995-06-01

Family

ID=26256599

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7904144A NL191332C (en) 1978-05-26 1979-05-25 Pharmaceutical preparation with the ethyl ester of (all-Z) -5,8,11,14,17-eicosapentaenoic acid.

Country Status (13)

Country Link
JP (1) JPS5515444A (en)
AU (1) AU527784B2 (en)
CA (1) CA1151068A (en)
CH (1) CH644267A5 (en)
DE (1) DE2831507A1 (en)
ES (1) ES480921A0 (en)
FR (1) FR2426461A1 (en)
IE (1) IE48287B1 (en)
IL (1) IL55227A (en)
IT (1) IT1116505B (en)
NL (1) NL191332C (en)
NZ (1) NZ187908A (en)
SE (1) SE448678B (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5735512A (en) * 1980-06-27 1982-02-26 Nippon Oil & Fats Co Ltd Preventive and remedy for thrombosis
JPS59172416A (en) * 1983-03-18 1984-09-29 Terumo Corp Fat transfusion solution
FR2548021B1 (en) * 1983-06-29 1986-02-28 Dick P R PROLONGED AND CONTINUOUS DERMAL PHARMACEUTICAL COMPOSITIONS BASED ON ESSENTIAL FATTY ACIDS
CA1239587A (en) * 1983-10-24 1988-07-26 David Rubin Combined fatty acid composition for lowering blood cholestrol and triglyceride levels
JPS60132916A (en) * 1983-12-21 1985-07-16 Nisshin Oil Mills Ltd:The Food or drug for preventing thrombosis
US4752618A (en) * 1984-07-12 1988-06-21 New England Deaconess Hospital Method of minimizing efects of infection through diet
JPH0748991B2 (en) * 1984-08-29 1995-05-31 日本油脂株式会社 Tube feeding composition
GB8710780D0 (en) * 1987-05-07 1987-06-10 Scras Opthalmological application of eicosapentaenoic acid
GB8819110D0 (en) * 1988-08-11 1988-09-14 Norsk Hydro As Antihypertensive drug & method for production
US5922345A (en) * 1990-12-07 1999-07-13 Scotia Holdings Plc Nutrition
WO1993020717A2 (en) * 1992-04-13 1993-10-28 Research Corporation Technologies, Inc. Reducing gastrointestinal irritation in infant nutrition
NL9401743A (en) * 1994-10-20 1996-06-03 Prospa Bv Salts of amino alcohols and pharmaceutical formulations containing them.
DE19503993A1 (en) * 1995-02-08 1996-08-14 Johann Friedrich Dr Med Desaga Enteral product contg n-3-fatty acid or deriv and medium chain length tri:glyceride
DE10056351A1 (en) * 2000-11-14 2002-05-29 Weylandt Karsten Henrich Pharmaceutical preparation containing omega-3 fatty acids and other active substances e.g. an antiinflammatory, cyclooxygenase II inhibitor, 5-lipoxygenase inhibitor or platelet aggregation inhibitor
GB0403247D0 (en) 2004-02-13 2004-03-17 Tillotts Pharma Ag A pharmaceutical composition
BRPI1011876B1 (en) 2009-04-29 2020-03-31 Amarin Pharma, Inc. STABLE PHARMACEUTICAL COMPOSITIONS UNDERSTANDING EICOSAPENTAENOIC ETHYLACID (ETHYL-EPA) AND USE OF THE SAME TO TREAT OR PREVENT A CARDIOVASCULAR DISEASE
NZ624963A (en) 2009-04-29 2016-07-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
CN102625847A (en) 2009-06-15 2012-08-01 阿马里纳制药公司 Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
AU2010298222B2 (en) 2009-09-23 2017-01-05 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same
US20130131170A1 (en) 2011-11-07 2013-05-23 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
ES2891473T3 (en) 2012-01-06 2022-01-28 Amarin Pharmaceuticals Ie Ltd Compositions and methods for reducing high sensitivity levels (hs-CRP) in a subject
SG10201913645RA (en) 2012-06-29 2020-03-30 Amarin Pharmaceuticals Ie Ltd Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
WO2014074552A2 (en) 2012-11-06 2014-05-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
US20140187633A1 (en) 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
SG11201505460WA (en) 2013-02-06 2015-08-28 Agency Science Tech & Res Methods for reducing aggregate levels in protein preparations by treatment with thio-heterocyclic cations
US9452151B2 (en) 2013-02-06 2016-09-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US9624492B2 (en) 2013-02-13 2017-04-18 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US10966968B2 (en) 2013-06-06 2021-04-06 Amarin Pharmaceuticals Ireland Limited Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
US20150065572A1 (en) 2013-09-04 2015-03-05 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing prostate cancer
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
US10561631B2 (en) 2014-06-11 2020-02-18 Amarin Pharmaceuticals Ireland Limited Methods of reducing RLP-C
WO2015195662A1 (en) 2014-06-16 2015-12-23 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acids
US10406130B2 (en) 2016-03-15 2019-09-10 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
US10966951B2 (en) 2017-05-19 2021-04-06 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject having reduced kidney function
US11058661B2 (en) 2018-03-02 2021-07-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
MA51765A (en) 2018-09-24 2020-12-16 Amarin Pharmaceuticals Ie Ltd METHODS OF REDUCING THE RISK OF CARDIOVASCULAR EVENTS IN A SUBJECT

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE319677B (en) * 1965-03-27 1970-01-19 Sumitomo Chemical Co
FR2097036A1 (en) * 1970-07-29 1972-03-03 Sopharga Lab Lipids contg fatty acids - for treatment of atheroslerosis
GB1476624A (en) * 1973-05-30 1977-06-16 Cepbepe Tranquiliser medicaments
GB1580444A (en) * 1976-11-04 1980-12-03 Bio Oil Res Pharmaceutical compositions
JPS6257605A (en) * 1985-09-05 1987-03-13 Kaizuka Kazutoshi Method for extracting effective component from multiple-element mineral

Also Published As

Publication number Publication date
DE2831507C2 (en) 1989-07-13
DE2831507A1 (en) 1979-11-29
IE48287B1 (en) 1984-11-28
SE448678B (en) 1987-03-16
FR2426461B1 (en) 1983-02-11
NL191332B (en) 1995-01-02
AU3808478A (en) 1980-01-17
JPS5515444A (en) 1980-02-02
CH644267A5 (en) 1984-07-31
NZ187908A (en) 1984-05-31
IL55227A (en) 1982-12-31
ES8104983A1 (en) 1981-05-16
IE791023L (en) 1979-11-26
CA1151068A (en) 1983-08-02
SE7904570L (en) 1979-11-27
FR2426461A1 (en) 1979-12-21
ES480921A0 (en) 1981-05-16
IL55227A0 (en) 1978-09-29
IT1116505B (en) 1986-02-10
AU527784B2 (en) 1983-03-24
NL7904144A (en) 1979-11-28
IT7947717A0 (en) 1979-01-19

Similar Documents

Publication Publication Date Title
NL191332C (en) Pharmaceutical preparation with the ethyl ester of (all-Z) -5,8,11,14,17-eicosapentaenoic acid.
NO862734L (en) PROCEDURE FOR THE PREPARATION OF HYALURONIC ACID ESTERS.
RO86355A (en) PROCESS FOR THE PREPARATION OF (S) -EPEMER OF THE ACID ESTER 7-BETA-MALONAMIDE-7-ALFA-METHO-3-TETRAZOLYL-TOMETHYL-1-DETHALYL-
NL178247C (en) PROCESS FOR THE PREPARATION OF BUTANEICARBONIC ACID ESTERS.
NO147949C (en) CONTINUOUS PROCEDURE FOR THE PREPARATION OF CARBOXYL ACID ACIDS.
ES513831A0 (en) "PROCEDURE FOR THE PREPARATION OF 6-HYDROXY-2-BENZOTIAZOLSULFONAMIDE CARBOXYL ESTERS".
NL7900264A (en) 4-PYRIDONE-3-CARBONIC ACID DERIVATIVES AND THEIR PREPARATION.
DK153279A (en) 1,3-DIBENZOIC ACID ESTERS OF 17ALFA-ETHYNYL-7ALFA-METHYL-1,3,5 (10) -OESTRATRIENE-1,3,17BETA-TRIOLS AND PROCEDURES FOR THE PREPARATION
TR20212A (en) STABILIZED ACID ACIDS, MANUFACTURED PROCEDURES AND USES
NL189910B (en) PROCESS FOR THE PREPARATION OF RACEMIC P-HYDROXYAMIC ACID.
IL57591A0 (en) The preparation of chlorostyryl-cyclopropane carboxylic acid derivatives
BE879937A (en) PROCESS FOR THE PREPARATION OF ALPHA-OMEGA-DICARBOXYLIC ACIDS
ATE16806T1 (en) 3-METHYLFLAVONE-8-CARBOXYL ACID ESTERS.
AR241108A2 (en) Pyrethroids
NL7802102A (en) PROCESS FOR THE PREPARATION OF PHENYLGLYOXYL ACID ESTERS.
NL7701641A (en) PROCEDURE FOR THE PREPARATION OF A CYCLOPANICARBONIC ACID ESTER.
BE888336A (en) Process for the preparation of cyclopropanecarboxylic acid ester derivatives,
NO164598C (en) PROCEDURE FOR THE PREPARATION OF CHLORMETYL ESTERS OF PENICILLAN ACIDS.
NL177590C (en) MULTI-STAGE PROCESS FOR THE PREPARATION OF DI-N-PROPYLACACIC ACID.
DK529580A (en) propionic acid esters
JPS5515472A (en) 22cyclopropyllpyrimidinee44yllthionophosphoric acid esters*their manufacture and their use as insecticide and miticide
IL60604A (en) 4-fluoro-3-bromo-benzoyl-fluoride,its preparation and its use for the preparation of the alpha-cyano-4-fluoro-3-phenoxybenzyl ester of permethric acid
AR221386A1 (en) PROCEDURE FOR THE PREPARATION OF BASIC ESTERS OF SUBSTITUTED HYDROXYCLOHEXANCARBOXYLIC ACIDS
NL7713616A (en) PROCESS FOR THE PREPARATION OF 0.0-DIALKYL -S- (N-METHYLCARBOXAMIDOMETHYL) -THIOLPHOSPHORIC ACID ESTERS.
NL7709502A (en) PROCESS FOR THE PREPARATION OF 17 (BETA) -HYDROXY-3-OXO-17 (ALPHA) -PREGN-4-EEN-21-CARBONIC ACID GAMMA-LACTONE.

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BA A request for search or an international-type search has been filed
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: BANG EN DR. JORN DYERBERG. DR. HANS OLAF -

BB A search report has been drawn up
BC A request for examination has been filed
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: MOCHIDA PHARMACEUTICAL CO., LTD. EN NIPPON SUISAN

V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 19990525